The effect of showdomycin on glycolipid formation. Inhibition of glucosyl-phosphoryl-dolichol in aorta and stimulation of glucosylceramide in yeast.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects / Q000378:metabolism*; D002554:Cerebrosides / Q000096:biosynthesis*; D005947:Glucose / Q000031:analogs & derivatives; D005958:Glucosephosphates / Q000378:metabolism; D005963:Glucosylceramides / Q000096:biosynthesis*; D006017:Glycolipids / Q000378:metabolism*; D007700:Kinetics; D011103:Polyisoprenyl Phosphate Monosaccharides / Q000096:biosynthesis*; D011105:Polyisoprenyl Phosphate Sugars / Q000096:biosynthesis*; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000378:metabolism*; D012787:Showdomycin / Q000494:pharmacology*; D013552:Swine; D014532:Uridine Diphosphate Glucose / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D002554:Cerebrosides; D005958:Glucosephosphates; D005963:Glucosylceramides; D006017:Glycolipids; D011103:Polyisoprenyl Phosphate Monosaccharides; D011105:Polyisoprenyl Phosphate Sugars; D012787:Showdomycin; D005947:Glucose; D014532:Uridine Diphosphate Glucose